These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 16014574
1. Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus. Sarkis A, Ito O, Mori T, Kohzuki M, Ito S, Verbalis J, Cowley AW, Roman RJ. Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1333-40. PubMed ID: 16014574 [Abstract] [Full Text] [Related]
2. Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR. Su P, Kaushal KM, Kroetz DL. Am J Physiol; 1998 Aug; 275(2):R426-38. PubMed ID: 9688677 [Abstract] [Full Text] [Related]
3. Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin II. Alonso-Galicia M, Maier KG, Greene AS, Cowley AW, Roman RJ. Am J Physiol Regul Integr Comp Physiol; 2002 Jul; 283(1):R60-8. PubMed ID: 12069931 [Abstract] [Full Text] [Related]
4. Inhibitors of 20-HETE formation promote salt-sensitive hypertension in rats. Hoagland KM, Flasch AK, Roman RJ. Hypertension; 2003 Oct; 42(4):669-73. PubMed ID: 12874093 [Abstract] [Full Text] [Related]
5. Effects of converting enzyme inhibitors on renal P-450 metabolism of arachidonic acid. Ito O, Omata K, Ito S, Hoagland KM, Roman RJ. Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R822-30. PubMed ID: 11171663 [Abstract] [Full Text] [Related]
7. Role of 20-hydroxyeicosatetraenoic acid in altering vascular reactivity in diabetes. Yousif MH, Benter IF, Dunn KM, Dahly-Vernon AJ, Akhtar S, Roman RJ. Auton Autacoid Pharmacol; 2009 Jan; 29(1-2):1-12. PubMed ID: 19302551 [Abstract] [Full Text] [Related]
8. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Wang MH, Stec DE, Balazy M, Mastyugin V, Yang CS, Roman RJ, Schwartzman ML. Arch Biochem Biophys; 1996 Dec 15; 336(2):240-50. PubMed ID: 8954571 [Abstract] [Full Text] [Related]
9. Age-related changes in renal cytochrome P-450 arachidonic acid metabolism in spontaneously hypertensive rats. Omata K, Abraham NG, Escalante B, Schwartzman ML. Am J Physiol; 1992 Jan 15; 262(1 Pt 2):F8-16. PubMed ID: 1733300 [Abstract] [Full Text] [Related]
10. The effect of isoniazid on CYP2E1- and CYP4A-mediated hydroxylation of arachidonic acid in the rat liver and kidney. Poloyac SM, Tortorici MA, Przychodzin DI, Reynolds RB, Xie W, Frye RF, Zemaitis MA. Drug Metab Dispos; 2004 Jul 15; 32(7):727-33. PubMed ID: 15205388 [Abstract] [Full Text] [Related]
11. Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. Oyekan AO, Youseff T, Fulton D, Quilley J, McGiff JC. J Clin Invest; 1999 Oct 15; 104(8):1131-7. PubMed ID: 10525052 [Abstract] [Full Text] [Related]
12. Renal 20-hydroxyeicosatetraenoic acid synthesis during pregnancy. Wang MH, Zand BA, Nasjletti A, Laniado-Schwartzman M. Am J Physiol Regul Integr Comp Physiol; 2002 Feb 15; 282(2):R383-9. PubMed ID: 11792647 [Abstract] [Full Text] [Related]
14. Inhibitors of 20-hydroxyeicosatetraenoic acid (20-HETE) formation attenuate the natriuretic effect of dopamine. Fernandez MM, Gonzalez D, Williams JM, Roman RJ, Nowicki S. Eur J Pharmacol; 2012 Jul 05; 686(1-3):97-103. PubMed ID: 22575524 [Abstract] [Full Text] [Related]
15. Cytochrome P-450 metabolites in renal circulation and excretion--interaction with the nitric oxide (NO) system. Kompanowska-Jezierska E, Kuczeriszka M. J Physiol Pharmacol; 2008 Dec 05; 59 Suppl 9():137-49. PubMed ID: 19261977 [Abstract] [Full Text] [Related]
16. Cytochrome P-450 inhibition attenuates hypertension induced by reductions in uterine perfusion pressure in pregnant rats. Llinás MT, Alexander BT, Capparelli MF, Carroll MA, Granger JP. Hypertension; 2004 Mar 05; 43(3):623-8. PubMed ID: 14757776 [Abstract] [Full Text] [Related]
18. Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy. Luo P, Zhou Y, Chang HH, Zhang J, Seki T, Wang CY, Inscho EW, Wang MH. Am J Physiol Renal Physiol; 2009 Mar 05; 296(3):F556-63. PubMed ID: 19129258 [Abstract] [Full Text] [Related]
19. Altered release of cytochrome p450 metabolites of arachidonic acid in renovascular disease. Minuz P, Jiang H, Fava C, Turolo L, Tacconelli S, Ricci M, Patrignani P, Morganti A, Lechi A, McGiff JC. Hypertension; 2008 May 05; 51(5):1379-85. PubMed ID: 18378855 [Abstract] [Full Text] [Related]
20. Role of epoxyeicosatrienoic acids in renal functional response to inhibition of NO production in the rat. Ogungbade GO, Akinsanmi LA, Jiang H, Oyekan AO. Am J Physiol Renal Physiol; 2003 Nov 05; 285(5):F955-64. PubMed ID: 12865253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]